Vertex Pharmaceuticals (VRTX) Cash from Investing Activities Growth (5y) (2014 - 2026)
Vertex Pharmaceuticals (VRTX) Cash from Investing Activities Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.19% |
| Dec 31, 2025 | -26.05% |
| Sep 30, 2025 | 13.95% |
| Jun 30, 2025 | -54.27% |
| Mar 31, 2025 | -30.34% |
| Dec 31, 2024 | 1.73% |
| Sep 30, 2024 | -6.92% |
| Jun 30, 2024 | -56.00% |
| Mar 31, 2024 | -122.54% |
| Dec 31, 2023 | -85.00% |
| Sep 30, 2023 | -18.73% |
| Jun 30, 2023 | -21.18% |
| Mar 31, 2023 | -226.97% |
| Dec 31, 2022 | 59.88% |
| Sep 30, 2022 | -11.27% |
| Jun 30, 2022 | 4.22% |
| Mar 31, 2022 | 20.54% |
| Dec 31, 2021 | -22.49% |
| Sep 30, 2021 | -28.62% |
| Jun 30, 2021 | -6.64% |